Clinical Trial utilizing optogenetics to start for Retinitis Pigmentosa soon

(c) nature.com

RetroSense Therapeutics’ Investigational New Drug (IND) application for gene therapy based clinical trial for their product RST-001 has received clearance from the US Food and Drug Administration. RetroSense is developing RST-001 for the treatment of retinitis pigmentosa, a genetic condition that leads to the progressive degeneration of rod and cone photoreceptors (cells found in the retina that sense light), resulting in severe vision loss and blindness. With its IND now in effect, RetroSense expects to initiate a Phase I/II clinical trial by year-end in order to evaluate the safety and, potentially, efficacy of RST-001.

Microglia - a potential therapeutic target in Retinitis Pigmentosa

Spider-like cells inside the brain, spinal cord and eye hunt for invaders, capturing and then devouring them. These cells, called microglia, often play a beneficial role by helping to clear trash and protect the central nervous system against infection. But a new study by researchers at the National Eye Institute (NEI) shows that they also accelerate damage wrought by blinding eye disorders, such as retinitis pigmentosa.

World's first-ever braille tablet has been developed

The first-ever braille tablet has been developed, using a new liquid-based technology to create tactile relief outputting braille, graphics and maps for the blind and partially sighted.

Berkeley Architect sustains his vision despite blindness

Oh, that we could see as clearly as blind architect Chris Downey. Leading his UC Berkeley seminar students to equitable, barrier-eliminating design solutions or consulting on a 170,000-square-foot blind rehab center at the Veterans Affairs center in Palo Alto or filling the stroke seat on his East Bay Rowing Club team, the 52-year-old Piedmont architect and teacher says he lacks sight, but is not without vision.

Tablet computers for the blind in development

Is Braille on the way out? Do we have enough interest in teaching Braille to visually impaired students? Considering some of the subject matter cannot be explained to them by voice, are there any attempts to make this means of communication more accessible via smartphones and technology in the current age? Surprising to some, there are attempts being made to develop this technology to help the visually impaired students.

Intas launches RAZUMAB, the first biosimilar to Lucentis (ranibizumab)

Intas Pharmaceuticals has launched RAZUMAB, its biosimilar to Lucentis (ranibizumab).

Students in Birmingham develop a smart cane for the blind

A revolutionary ‘smart’ cane enabling the visually impaired to instantly identify friends and family could be available soon, thanks to students at Birmingham City University.